Fewer Injection-Related Side Effects While all GLP-1 medications can cause gastrointestinal side effects such as nausea and vomiting, oral medications may reduce the risk of injection-related issues, such as site reactions or discomfort
Improving the efficiency of fat use as fuel during exercise
employers approximately $82.3 billion, while health-related presenteeism associated with obesity had a cost of $160.3 billion.[50] Additionally, productivity losses due to presenteeism amount to an estimated 2 percent reduction in total output for these individuals
Another registration number used in the document, 4000006770415, is also non-existent in the FDA database
Choose Not on a GLP-1 on the medication step
doi: 10.3389/fnagi.2026.1851072 Received 09 April 2026 Revised 18 May 2026 Accepted 20 May 2026 Published 05 June 2026 Volume 18 - 2026 Edited by Scott E